TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 10377608

Group type: EXPERIMENTAL
Intervention: Experimental blackcurrant juice drink with calcium
Number of subjects: 12

Group type: COMPARATOR
Intervention: Orange juice
Number of subjects: 12

Group type: COMPARATOR
Intervention: Water
Number of subjects: 12

Group type: COMPARATOR
Intervention: Proprietary blackcurrant juice drink
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Experimental blackcurrant juice drink with calcium (in vitro)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Orange juice (in vitro)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Water (in vitro)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Proprietary blackcurrant juice drink (in vitro)
Number of subjects: 12
Study: 8882755

Group type: EXPERIMENTAL
Intervention: Capsaicin applied locally (30 microns), treatment given once a week for 5 consecutive weeks
Number of subjects: 15

Group type: COMPARATOR
Intervention: Control group (equal number of patients)
Number of subjects: 15
Study: 1944720

Group type: EXPERIMENTAL
Intervention: Oral phosphatidylcholine at 900 mg/day for 8 weeks
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study: 6416286

Group type: EXPERIMENTAL
Intervention: Disodium cromoglycate (DSCG) aerosol (10 mg) before exercise
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Disodium cromoglycate (DSCG) aerosol (10 mg) after exercise
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 29161888

Group type: EXPERIMENTAL
Intervention: 1% bird's nest fern extract (BNFE)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Higher polysaccharide content in BNFE
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: BNFE
Number of subjects: 0
Study: 28832179

Group type: EXPERIMENTAL
Intervention: Multimedia educational intervention
Number of subjects: 200

Group type: COMPARATOR
Intervention: Usual education (Control)
Number of subjects: 200
Study: 26503077

Group type: EXPERIMENTAL
Intervention: 5 h/day CCM treatment
Number of subjects: 19

Group type: COMPARATOR
Intervention: 12 h/day CCM treatment
Number of subjects: 19
Study: 24946625

Group type: EXPERIMENTAL
Intervention: Acupuncture treatment (5 times a week for 8 weeks)
Number of subjects: 126

Group type: COMPARATOR
Intervention: Conventional treatment
Number of subjects: 126
Study: 22261571

Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (NAC; 1 g/d)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Glutamine (Gln; 20 g/d)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Healthy controls (20 participants, 10 men and 10 women, aged 20-59 years)
Number of subjects: 12
Study: 19921150

Group type: EXPERIMENTAL
Intervention: Beta-lactam antibiotic regimen (weekly cycling of ceftriaxone, amoxicillin-clavulanic acid)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Fluoroquinolone regimen
Number of subjects: 0
Study: 17391168

Group type: EXPERIMENTAL
Intervention: Metformin 1 g twice daily
Number of subjects: 96

Group type: COMPARATOR
Intervention: Repaglinide 2 mg thrice daily
Number of subjects: 96
Study: 15755766

Group type: COMPARATOR
Intervention: Ghrelin concentrations in girls with AN
Number of subjects: 22

Group type: COMPARATOR
Intervention: Secretory burst amplitude in girls with AN
Number of subjects: 22

Group type: COMPARATOR
Intervention: Pulsatile ghrelin secretion in girls with AN
Number of subjects: 22

Group type: COMPARATOR
Intervention: Fasting ghrelin in girls with AN
Number of subjects: 22

Group type: COMPARATOR
Intervention: Valley ghrelin in girls with AN
Number of subjects: 22

Group type: COMPARATOR
Intervention: Ghrelin parameters in girls with AN
Number of subjects: 22

Group type: COMPARATOR
Intervention: Insulin resistance in girls with AN
Number of subjects: 22
Study: 12041843

Group type: EXPERIMENTAL
Intervention: Counselling from specialized nurses using behavioural and lifestyle modification sessions every 4 weeks for 25 weeks
Number of subjects: 421

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 421
Study: 9620322

Group type: EXPERIMENTAL
Intervention: Early cyclosporine monotherapy
Number of subjects: 104

Group type: COMPARATOR
Intervention: Double-drug therapy (cyclosporine and steroids)
Number of subjects: 104
Study: 8571077

Group type: EXPERIMENTAL
Intervention: Beta-carotene (30 mg per day)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 2591470

Group type: EXPERIMENTAL
Intervention: Theo-Dur tablets with a balanced meal
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Dilatrane A.P. with a balanced meal
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Theo-Dur tablets with a hyperlipidic meal
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Dilatrane A.P. with a hyperlipidic meal
Number of subjects: 12
Study: 807224

Group type: EXPERIMENTAL
Intervention: Naproxen
Number of subjects: 877
Study: 31030946

Group type: EXPERIMENTAL
Intervention: Mixed lipid emulsion containing fish oil
Number of subjects: 230

Group type: COMPARATOR
Intervention: Soybean oil−based lipid emulsion (control)
Number of subjects: 230
Study: 27613881

Group type: EXPERIMENTAL
Intervention: Tobacco sold only at half the existing liquor stores
Number of subjects: 623

Group type: EXPERIMENTAL
Intervention: Tobacco sold only at pharmacies
Number of subjects: 623

Group type: COMPARATOR
Intervention: Annual tobacco tax increases
Number of subjects: 623
Study: 25359159

Group type: EXPERIMENTAL
Intervention: Insulin glargine, titrated to target fasting plasma glucose of 4.0-5.5 mmol/L for 24 weeks
Number of subjects: 978

Group type: COMPARATOR
Intervention: Liraglutide, escalated to the highest approved clinical dose of 1.8 mg daily for 24 weeks
Number of subjects: 978
Study: 23746076

Group type: EXPERIMENTAL
Intervention: Endoscopic Mucosal Resection (EMR)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Transanal Endoscopic Microsurgery (TEM)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Endoscopic Mucosal Resection (EMR) and Transanal Endoscopic Microsurgery (TEM)
Number of subjects: 24
Study: 16822110

Group type: EXPERIMENTAL
Intervention: Telephone-based coping skills training (CST)
Number of subjects: 328

Group type: COMPARATOR
Intervention: Usual medical care (UMC)
Number of subjects: 328
Study: 12464714

Group type: EXPERIMENTAL
Intervention: rizatriptan 10 mg
Number of subjects: 439

Group type: COMPARATOR
Intervention: ergotamine 1 mg/caffeine 100 mg
Number of subjects: 439
Study: 10888149

Group type: EXPERIMENTAL
Intervention: 30 degree left lateral position
Number of subjects: 35

Group type: COMPARATOR
Intervention: Supine position
Number of subjects: 35
Study: 8803398

Group type: EXPERIMENTAL
Intervention: 10 percent carbamide peroxide gel
Number of subjects: 52

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 52
Study: 1627717

Group type: COMPARATOR
Intervention: Letterbox drops (leaflets distributed to households)
Number of subjects: 3984

Group type: COMPARATOR
Intervention: Invitations for friends (including pamphlet and contact information)
Number of subjects: 3984
Study: 6371285

Group type: EXPERIMENTAL
Intervention: Continuous epidural analgesia with bupivacaine (0.25% or 0.125%) and morphine (3 mg injected twice a day)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Epidural morphine (3 mg injected twice a day)
Number of subjects: 11
Study: 31912485

Group type: EXPERIMENTAL
Intervention: CBT-based intervention (2 sessions)
Number of subjects: 133

Group type: COMPARATOR
Intervention: Treatment-as-usual (TAU)
Number of subjects: 133
Study: 31330252

Group type: EXPERIMENTAL
Intervention: PROMIS 4-item scale
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Numeric Rating Scale (NRS)
Number of subjects: 300

Group type: COMPARATOR
Intervention: Non-PROMIS legacy scale
Number of subjects: 300
Study: 28152175

Group type: EXPERIMENTAL
Intervention: Baseline restricted life-space
Number of subjects: 478

Group type: COMPARATOR
Intervention: Baseline unrestricted life-space
Number of subjects: 478
Study: 25789616

Group type: EXPERIMENTAL
Intervention: GSK933776 0.001-6 mg/kg (intravenous administration)
Number of subjects: 50
Study: 23863537

Group type: COMPARATOR
Intervention: Transrectal ultrasound (TRUS) volumetry
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Magnetic resonance imaging (MRI) volumetry
Number of subjects: 46

Group type: COMPARATOR
Intervention: TRUS versus MRI volumetry
Number of subjects: 46
Study: 21411613

Group type: EXPERIMENTAL
Intervention: Probiotics alone (Lactobacillus rhamnosus strains GG and LC705, Propionibacterium freudenreichii ssp. shermanii JS, and Bifidobacterium breve Bb99, 2 × 10(10) CFU/d)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Probiotics with GOS (3.8 g/d)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Probiotics with GOS and rye bread (minimum 120 g/d)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Probiotics with GOS
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Probiotics alone
Number of subjects: 18
Study: 19757002

Group type: EXPERIMENTAL
Intervention: CT scan of the left atrium and esophagus integrated into the 3D electroanatomical map
Number of subjects: 18

Group type: COMPARATOR
Intervention: Esophagus tag integrated into the electroanatomic LA map
Number of subjects: 18
Study: 17554100

Group type: EXPERIMENTAL
Intervention: Application of evidence-based model for critically appraising research evidence
Number of subjects: 1

Group type: EXPERIMENTAL
Intervention: Use of letter grade scale for quality assessment
Number of subjects: 1

Group type: EXPERIMENTAL
Intervention: Checklist-driven model for evidence application
Number of subjects: 1
Study: 15515440

Group type: EXPERIMENTAL
Intervention: Environmental design intervention (large clock and sign with large lettering identifying mealtimes)
Number of subjects: 35
Study: 11566459

Group type: EXPERIMENTAL
Intervention: Ketoprofen (200 mg daily) for 1 week followed by ketoprofen (200 mg daily) and aspirin (325 mg daily)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Ketoprofen (200 mg daily) for 1 week followed by ketoprofen (200 mg daily) alone
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Ketoprofen (200 mg daily) with aspirin (325 mg daily)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Ketoprofen (200 mg daily) without aspirin
Number of subjects: 25
Study: 9745426

Group type: EXPERIMENTAL
Intervention: Estrogen (ethinyl estradiol, 12.5-50 ng/kg.day)
Number of subjects: 2

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2
Study: 7825702

Group type: EXPERIMENTAL
Intervention: Functional meal preparation group (n = 23)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Parquetry block assembly group (n = 22)
Number of subjects: 45
Study: 3373080

Group type: EXPERIMENTAL
Intervention: Dapsone (DDS) injection
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Monoacetyldapsone (MADDS) injection
Number of subjects: 74

Group type: COMPARATOR
Intervention: Comparison of DDS and MADDS
Number of subjects: 74
Study: 30465292

Group type: EXPERIMENTAL
Intervention: Divide-and-conquer technique (Group-1)
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Stop-and-chop technique (Group-2)
Number of subjects: 110

Group type: COMPARATOR
Intervention: Stop-and-chop technique (in second part of study)
Number of subjects: 110

Group type: COMPARATOR
Intervention: Divide-and-conquer technique (in second part of study)
Number of subjects: 110
Study: 29024079

Group type: EXPERIMENTAL
Intervention: Benzoyl peroxide 5% gel or cream
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Tretinoin 0.025% cream
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 0
Study: 25909676

Group type: EXPERIMENTAL
Intervention: Expanding transplants
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Plastic correction with local tissues
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Suture correction technique
Number of subjects: 0
Study: 24270291

Group type: EXPERIMENTAL
Intervention: Social environmental intervention
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Physical environmental intervention
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combined interventions
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Physical intervention with social intervention
Number of subjects: 0
Study: 21478286

Group type: EXPERIMENTAL
Intervention: Rituximab
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 19349144

Group type: EXPERIMENTAL
Intervention: Radiofrequency catheter ablation (RFCA)
Number of subjects: 61
Study: 16574999

Group type: EXPERIMENTAL
Intervention: Fixed dose of cisplatin in course 1
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: BSA-adjusted dose of cisplatin in course 2
Number of subjects: 25

Group type: COMPARATOR
Intervention: Normal population retrospective analysis
Number of subjects: 25
Study: 15389743

Group type: EXPERIMENTAL
Intervention: Actual laser therapy (LLLT)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo laser therapy
Number of subjects: 60
Study: 11494959

Group type: EXPERIMENTAL
Intervention: sad with physical discomfort
Number of subjects: 139

Group type: EXPERIMENTAL
Intervention: happy with physical discomfort
Number of subjects: 139

Group type: COMPARATOR
Intervention: sad
Number of subjects: 139

Group type: COMPARATOR
Intervention: happy
Number of subjects: 139
Study: 9087156

Group type: EXPERIMENTAL
Intervention: Fenugreek seed powder
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Skin scratch test with fenugreek
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Immunoblotting with fenugreek extract
Number of subjects: 2
Study: 8460803

Group type: EXPERIMENTAL
Intervention: Laryngeal mask airway
Number of subjects: 10

Group type: COMPARATOR
Intervention: Guedel airway, bag and facemask
Number of subjects: 10
Study: 3817031

Group type: EXPERIMENTAL
Intervention: Vitamin E (high doses, orally administered)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 31114155

Group type: EXPERIMENTAL
Intervention: Fixed-dose combination (FDC) of amlodipine 10 mg/olmesartan 40 mg/rosuvastatin 20 mg
Number of subjects: 64

Group type: COMPARATOR
Intervention: Co-administration of FDC (amlodipine 10 mg/olmesartan 40 mg) and rosuvastatin 20 mg
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Both formulations
Number of subjects: 64
Study: 30142622

Group type: EXPERIMENTAL
Intervention: Serving
Number of subjects: 30
Study: 26621551

Group type: EXPERIMENTAL
Intervention: Telephone Monitoring and Counseling (TMC)
Number of subjects: 321

Group type: EXPERIMENTAL
Intervention: TMC-plus
Number of subjects: 321

Group type: COMPARATOR
Intervention: Treatment-as-usual (TAU)
Number of subjects: 321
Study: 25375054

Group type: EXPERIMENTAL
Intervention: Human fibrin glue (HFG)
Number of subjects: 468

Group type: COMPARATOR
Intervention: Suture polypropylene fixation
Number of subjects: 468
Study: 22487627

Group type: EXPERIMENTAL
Intervention: Ligasure
Number of subjects: 40

Group type: COMPARATOR
Intervention: Clip
Number of subjects: 40
Study: 20491709

Group type: EXPERIMENTAL
Intervention: 0.5 g EPA for 15 weeks
Number of subjects: 92
Study: 18587509

Group type: EXPERIMENTAL
Intervention: Biofeedback device
Number of subjects: 33

Group type: COMPARATOR
Intervention: Traditional physiotherapy intervention
Number of subjects: 33
Study: 16157232

Group type: EXPERIMENTAL
Intervention: Motivational group counseling followed by cognitive-behavioral group (12 sessions, 3 times per week for 4 weeks, followed by 36 sessions, 3 times per week for 12 weeks) plus information and referral (I&R) and peer advocacy
Number of subjects: 289

Group type: COMPARATOR
Intervention: Information and referral (I&R) plus peer advocacy
Number of subjects: 289

Group type: EXPERIMENTAL
Intervention: Motivational group counseling followed by cognitive-behavioral group plus I&R and peer advocacy
Number of subjects: 289
Study: 11948003

Group type: COMPARATOR
Intervention: 1000 mg ER
Number of subjects: 36

Group type: COMPARATOR
Intervention: 1500 mg ER
Number of subjects: 36

Group type: COMPARATOR
Intervention: ER formulation
Number of subjects: 36

Group type: COMPARATOR
Intervention: Higher ER doses
Number of subjects: 36
Study: 10319779

Group type: EXPERIMENTAL
Intervention: Acupressure and acupuncture (study group)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo (non-bead Acubands, control group)
Number of subjects: 100
Study: 8682824

Group type: EXPERIMENTAL
Intervention: Reamed nailing
Number of subjects: 50

Group type: COMPARATOR
Intervention: Unreamed nailing
Number of subjects: 50
Study: 1932837

Group type: EXPERIMENTAL
Intervention: Tumor response
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Phase II trials
Number of subjects: 0

Group type: COMPARATOR
Intervention: Phase III comparative trials
Number of subjects: 0
Study: 7053922

Group type: EXPERIMENTAL
Intervention: Frusemide (1 mg/kg)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Chlorthiazid (10 mg/Kg)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Frusemide (0.25‐0.5 mg/Kg)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Chlorthiazid (20 mg/Kg)
Number of subjects: 19
Study: 31374063

Group type: EXPERIMENTAL
Intervention: 0.05% cyclosporine ophthalmic emulsion (CsA OE)
Number of subjects: 240

Group type: COMPARATOR
Intervention: Vehicle control
Number of subjects: 240
Study: 29021370

Group type: EXPERIMENTAL
Intervention: Nutrition-focused MNCH
Number of subjects: 1300

Group type: COMPARATOR
Intervention: Standard MNCH
Number of subjects: 1300
Study: 26149189

Group type: EXPERIMENTAL
Intervention: l-carnitine 750 mg/d for 8 weeks
Number of subjects: 72

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 72
Study: 23311715

Group type: EXPERIMENTAL
Intervention: Carprofen
Number of subjects: 68

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 68
Study: 21659360

Group type: EXPERIMENTAL
Intervention: Fludarabine, Chlorambucil, and Fludarabine with Cyclophosphamide as first-line treatment
Number of subjects: 356
Study: 18022303

Group type: EXPERIMENTAL
Intervention: Left motor deficits (LPD)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Right substantia nigra (SN) volume
Number of subjects: 35

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Right motor deficits (RPD)
Number of subjects: 35
Study: 17072957

Group type: EXPERIMENTAL
Intervention: Distal splenorenal shunt (DSRS)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Endoscopic sclerotherapy (ES)
Number of subjects: 80
Study: 12013322

Group type: EXPERIMENTAL
Intervention: Pharmacotherapies for stroke risk factors
Number of subjects: 16148

Group type: EXPERIMENTAL
Intervention: Hypertension
Number of subjects: 16148

Group type: EXPERIMENTAL
Intervention: Hypercholesterolaemia
Number of subjects: 16148

Group type: EXPERIMENTAL
Intervention: Current smoking
Number of subjects: 16148

Group type: EXPERIMENTAL
Intervention: Cardiovascular agents
Number of subjects: 16148

Group type: EXPERIMENTAL
Intervention: Antiplatelet agents
Number of subjects: 16148

Group type: EXPERIMENTAL
Intervention: Angiotensin-converting enzyme inhibitors
Number of subjects: 16148
Study: 9864106

Group type: COMPARATOR
Intervention: Normal saline infusion under the right hemidiaphragm (Group B)
Number of subjects: 300

Group type: COMPARATOR
Intervention: Bupivacaine 1.5 mg/kg infusion under the right hemidiaphragm (Group C)
Number of subjects: 300

Group type: COMPARATOR
Intervention: Bupivacaine infusion with subhepatic drain (Group D)
Number of subjects: 300

Group type: COMPARATOR
Intervention: Normal saline plus bupivacaine infusion (Group E)
Number of subjects: 300

Group type: COMPARATOR
Intervention: Normal saline plus bupivacaine with subhepatic drain (Group F)
Number of subjects: 300
Study: 8560535

Group type: EXPERIMENTAL
Intervention: Albendazole
Number of subjects: 731

Group type: EXPERIMENTAL
Intervention: Mebendazole
Number of subjects: 731
Study: 1983610

Group type: EXPERIMENTAL
Intervention: Operative treatment
Number of subjects: 744

Group type: COMPARATOR
Intervention: Non-surgical therapy
Number of subjects: 744
Study: 1247378

Group type: EXPERIMENTAL
Intervention: Physical exercise plus biofeedback training
Number of subjects: 20

Group type: COMPARATOR
Intervention: Conventional physical exercise
Number of subjects: 20
Study: 7016242

Group type: EXPERIMENTAL
Intervention: Lateral subcutaneous sphincterotomy under general anaesthesia (n = 37)
Number of subjects: 71

Group type: COMPARATOR
Intervention: Lateral subcutaneous sphincterotomy under local anaesthesia (n = 34)
Number of subjects: 71
Study: 31613408

Group type: EXPERIMENTAL
Intervention: Myelomeningocele sac presence
Number of subjects: 404

Group type: EXPERIMENTAL
Intervention: Myelomeningocele sac size
Number of subjects: 404

Group type: COMPARATOR
Intervention: Myelomeningocele vs Myeloschisis
Number of subjects: 404

Group type: COMPARATOR
Intervention: Myelomeningocele with hindbrain herniation
Number of subjects: 404
Study: 28954570

Group type: EXPERIMENTAL
Intervention: Solution-Focused Brief Couple Therapy (SFBCT)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 100
Study: 27007594

Group type: EXPERIMENTAL
Intervention: Sucralfate mouthwash (every 6 hours)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 25102328

Group type: EXPERIMENTAL
Intervention: Naltrexone (NTX) 25 mg/d for 8 weeks
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 21925716

Group type: EXPERIMENTAL
Intervention: AZD0837 (150, 250 or 350 mg)
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: ximelagatran (36 mg twice daily)
Number of subjects: 65

Group type: COMPARATOR
Intervention: Vitamin K antagonist (VKA) titrated to INR of 2-3
Number of subjects: 65

Group type: COMPARATOR
Intervention: Control group (healthy elderly subjects)
Number of subjects: 65
Study: 20806988

Group type: EXPERIMENTAL
Intervention: Guanfacine XR (1-4 mg/day)
Number of subjects: 217

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 217
Study: 17851996

Group type: EXPERIMENTAL
Intervention: Nutritional counseling intervention (NC arm)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Nutrition intervention with oxandrolone (OX arm)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Nutrition intervention with progressive resistance training (PRT arm)
Number of subjects: 50
Study: 15758667

Group type: EXPERIMENTAL
Intervention: Current smokers
Number of subjects: 268

Group type: EXPERIMENTAL
Intervention: Previous smokers
Number of subjects: 268
Study: 12137879

Group type: EXPERIMENTAL
Intervention: Zona-free blastocyst transfer
Number of subjects: 240

Group type: COMPARATOR
Intervention: Zona-intact blastocyst transfer
Number of subjects: 240
Study: 10098789

Group type: EXPERIMENTAL
Intervention: Point-of-use water disinfection, safe storage, and community education
Number of subjects: 127
Study: 7762461

Group type: EXPERIMENTAL
Intervention: Home therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Hospital-based care
Number of subjects: 0